Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. - Wikidata - awgldk - TriplyDB

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

http://www.wikidata.org/entity/Q50579007

about

Acute hepatitis C: prevention and treatment ISG56 and IFITM1 proteins inhibit hepatitis C virus replication Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions Innate immune responses in hepatitis C virus infection Decoding the complexity of type I interferon to treat persistent viral infections Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis Novel Alpha Interferon (IFN- ) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN- 2b Therapy in a Subgenomic Replicon System Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C Interferon signaling and treatment outcome in chronic hepatitis C Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians Gene expression and hepatitis C virus infection Using high-throughput genomics to study hepatitis C: What determines the outcome of infection?Peginterferon Pharmacokinetics in African American and Caucasian American Patients With Hepatitis C Virus Genotype 1 Infection Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43 Antiviral activity and host gene induction by tamarin and marmoset interferon-α and interferon-γ in the GBV-B primary hepatocyte culture model Innate immune evasion by hepatitis C virus and West Nile virus Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.HIV/Hepatitis C Virus-Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do Disease-promoting effects of type I interferons in viral, bacterial, and coinfections Influence of host resistance on viral adaptation: hepatitis C virus as a case study S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes.Protein Interferon-Stimulated Gene 15 Conjugation Delays but Does Not Overcome Coronavirus Proliferation in a Model of Fulminant Hepatitis MAID : an effect size based model for microarray data integration across laboratories and platforms.The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.Involvement of MAP3K8 and miR-17-5p in poor virologic response to interferon-based combination therapy for chronic hepatitis C.Hepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cells SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver

P2860

Q22305934-B27BB2C1-C719-4BC9-89AE-DD5C6D8C9E72 Q24339446-197A6F3F-92D8-41BF-9112-B4DC5019151F Q26784252-53B58606-BF15-482C-AD96-BC744458CA58 Q27014831-EB26D127-550F-4A21-B8FB-93B3B5D5DC4F Q27023055-68C491DC-1CB4-4E01-B461-ACCAC30820D0 Q27023801-9BCA4BD8-FBAA-4C12-ADDA-8E6A024FEC57 Q27473268-06E5B976-1D64-419E-BDB9-88A9B5B98A81 Q27477758-84D0C84E-AF3F-4C6D-80ED-43F81F338AB6 Q27478298-1A314F8D-8F8D-4949-AB4A-2C0A88B816BA Q27486083-106D3759-10AC-4014-8191-34F34389A185 Q27486088-0720091E-D759-4672-83F6-D5A44EDC2DAE Q27488260-C795070B-5EF9-45A3-BBE1-17B27C573271 Q27488345-7B1C9AF3-1BFF-442E-968B-E75435B74DCF Q27488407-2E4EA0B9-7E34-48C9-9BC0-25A7CE5C44D1 Q27488869-7A6DFF1A-145D-4103-BA44-BB7EB2ACA6B4 Q27489129-C37208A1-033F-44BC-820C-BDEE15F10FC6 Q27489800-C2348EEC-6775-4B88-BE77-93FFF3B5EEBE Q27489865-8B3B1E60-BA12-43B0-9154-FC39F6E5ADD1 Q27490426-0BF6AD42-F4E0-4906-8A72-9F31B7621892 Q27490650-8D51A562-9014-4440-8A41-E06C8BE6D31C Q27491342-1577D3D9-043B-48BB-BBFB-80CA596FE052 Q28082841-3D339779-1E0F-4900-9950-5242FA3F80C7 Q28087595-CD5F8D77-CC55-433A-8C3A-7988BBA553AA Q28476040-FF024E49-044C-41EC-AF46-0599CACC01EC Q28478142-5C4B28AF-6A58-4525-82AB-717621149381 Q28534715-C6A2A844-7307-4EB1-9452-D55D7D94EC32 Q28728766-57F5D77D-FAF3-402A-895C-56289ED0F0C0 Q29615959-216EACDF-6BCE-4244-B599-124B51C9CBC7 Q30009516-7B5E4FF7-44BF-4E96-A05C-75F7FC70E087 Q30049307-9B42585B-55C5-4582-BF4B-54B3848B0B3C Q30482830-6C040D5D-826D-4F7C-B2AB-972D7E4731B1 Q33391782-0ACFE7E2-5A39-40B9-9416-E21409B06563 Q33400538-055DA837-5ADE-4F86-B1CD-B4DFBB8015D6 Q33569876-EA20670D-B2B5-47D6-B306-393071316B0C Q33597579-36500ED7-F1AA-47E2-82DB-135BF09C56BB Q33599325-2F76E411-DF4D-4376-B664-417B03D0F84D Q33664480-97DCD609-AFFB-42DD-8EA5-97EAC9842CA4 Q33719537-1141F1B3-E632-412B-9286-14C6110D40E2 Q33726212-2BFF2596-C2F6-41D2-A0FA-233F852236F2 Q33748950-AA1E98B9-44BA-4C19-B027-D7619755957B

P2860

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

http://www.wikidata.org/entity/Q50579007

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Hepatic gene expression discri ...... c hepatitis C viral infection.

@en

Hepatic gene expression discri ...... c hepatitis C viral infection.

@nl

type

label

Hepatic gene expression discri ...... c hepatitis C viral infection.

@en

Hepatic gene expression discri ...... c hepatitis C viral infection.

@nl

prefLabel

Hepatic gene expression discri ...... c hepatitis C viral infection.

@en

Hepatic gene expression discri ...... c hepatitis C viral infection.

@nl

P1433

Q50579007-0E195A8B-7397-42E8-BA1E-15A7D8249242

P1476

Q50579007-6CFC3537-1328-491D-BD6D-01AC94F8EE56

P2093

Q50579007-15E3F085-0E54-4F69-9F73-EFE103B0E1F8

Q50579007-17A73EBB-C14E-4E10-9937-E4643A68DCF7

Q50579007-56C246E2-7486-4FCF-B241-43E85D2B58A8

Q50579007-58451074-636F-4CB8-9E42-79F5850E906A

Q50579007-6925100E-08D5-4270-A726-23F8B12BEBF4

Q50579007-B6EA50AF-CAE4-4F3D-84FA-9F24C147BA08

Q50579007-DF8C9C3A-B468-460F-9F77-41796AC138EF

P304

Q50579007-F31BF890-1683-4F5B-A394-D06C5269E0A2

P31

Q50579007-B00B7428-BC07-409C-AC1B-518C10B7DCC2

P356

Q50579007-ED2AF0A2-32CB-4A00-9E5F-BDFC6EED7146

P407

Q50579007-87B4BF69-7281-4086-9607-959B735035C6

P433

Q50579007-E9AE6123-DCBE-4C4F-9728-D02B476F4F1E

P478

Q50579007-ED351AD5-FF83-44B7-8757-2327D1D0EEC4

P50

Q50579007-09424960-2A06-4DE9-B6B8-1D8CA57A0CE7

Q50579007-C865F8AA-8B86-4EC1-8725-704B8217C509

P577

Q50579007-4AB21888-A193-42A3-BD41-5EACC52C615C

P5875

Q50579007-AB3F029D-2935-49E0-9CEA-508447E5A7E0

P698

Q50579007-2EE6DFC7-E961-4806-A180-C04CE18964A9

P356

J.GASTRO.2005.01.059

P1433

Gastroenterology

P1476

Hepatic gene expression discri ...... c hepatitis C viral infection.

@en

P2093

Catalina Coltescu

http://www.w3.org/2001/XMLSchema#string

Ivan Borozan

http://www.w3.org/2001/XMLSchema#string

Jenny Heathcote

http://www.w3.org/2001/XMLSchema#string

Jing Sun

http://www.w3.org/2001/XMLSchema#string

Jordan Feld

http://www.w3.org/2001/XMLSchema#string

Laura-Lee Tannis

http://www.w3.org/2001/XMLSchema#string

Limin Chen

http://www.w3.org/2001/XMLSchema#string

P304

1437-1444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2005.01.059

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Ian D McGilvray

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7854324

http://www.w3.org/2001/XMLSchema#string

P698

15887125

http://www.w3.org/2001/XMLSchema#string